Ratings by Piper Sandler (David Westenberg)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/23/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 6/11/2026 | Waters Corp. | WAT | New Coverage | Neutral (N/A) |
371.15 (377.15) |
1.62% | Details | |
| 6/11/2026 | Twist Bioscience | TWST | New Coverage | Overweight (N/A) |
70.06 (95.28) |
36% | Details | |
| 6/11/2026 | Thermo Fisher Scientific | TMO | New Coverage | Neutral (N/A) |
494.07 (508.50) |
2.92% | Details | |
| 6/11/2026 | Bio-Techne Corp. | TECH | New Coverage | Neutral (N/A) |
54.41 (70.50) |
29.57% | Details | |
| 6/11/2026 | Danaher | DHR | New Coverage | Neutral (N/A) |
188.41 (194.51) |
3.24% | Details | |
| 6/11/2026 | Agilent | A | New Coverage | Neutral (N/A) |
135.48 (136.97) |
1.1% | Details | |
| 5/6/2026 | GRAIL, Inc. | GRAL | Maintain | Neutral (N/A) |
|
Details | ||
| 5/5/2026 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 4/21/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 4/10/2026 | GRAIL, Inc. | GRAL | New Coverage | Neutral (N/A) |
50.78 (67.29) |
32.51% | Details | |
| 4/10/2026 | Caris Life Sciences Inc | CAI | New Coverage | Neutral (N/A) |
19.51 (19.26) |
-1.28% | Details | |
| 3/31/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/16/2026 | BillionToOne Inc | BLLN | Maintain | Overweight (N/A) |
|
Details | ||
| 3/10/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 2/24/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/9/2026 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/22/2026 | Zoetis Inc. | ZTS | Downgrade | Neutral (Overweight) |
123.24 (78.47) |
-36.33% | Details | |
| 1/22/2026 | Elanco Animal Health | ELAN | Upgrade | Overweight (Neutral) |
24.16 (24.24) |
0.33% | Details | |
| 1/13/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2026 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 12/15/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 12/10/2025 | BillionToOne Inc | BLLN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/1/2025 | BillionToOne Inc | BLLN | New Coverage | Overweight (N/A) |
127.85 (112.82) |
-11.76% | Details | |
| 11/24/2025 | Exact Sciences | EXAS | Downgrade | Neutral (Overweight) |
100.90 (104.91) |
3.97% | Details | |
| 11/11/2025 | 10X Genomics | TXG | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2025 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2025 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 10/27/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/22/2025 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 10/22/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 10/15/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/3/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 9/11/2025 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/11/2025 | 10X Genomics | TXG | New Coverage | Neutral (N/A) |
13.50 (35.29) |
161.41% | Details | |
| 8/11/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2025 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2025 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2025 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 7/28/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/9/2025 | GeneDx | WGS | New Coverage | Overweight (N/A) |
85.74 (65.90) |
-23.14% | Details | |
| 7/2/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/12/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 5/6/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/6/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 4/22/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 4/14/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 3/19/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/6/2025 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2025 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2025 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/27/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/20/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/10/2025 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/10/2025 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/3/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/21/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 1/3/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 11/26/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/12/2024 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/28/2024 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 10/1/2024 | Laboratory Corporation of America | LH | New Coverage | Neutral (N/A) |
222.10 (266.82) |
20.14% | Details | |
| 9/27/2024 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 9/20/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 9/12/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2024 | Tempus AI Inc | TEM | New Coverage | Neutral (N/A) |
38.93 (54.59) |
40.23% | Details | |
| 7/29/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/19/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 7/1/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/13/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2024 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/15/2024 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 3/12/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/6/2024 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2024 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2024 | IDEXX Laboratories | IDXX | Downgrade | Neutral (Overweight) |
524.98 (564.34) |
7.5% | Details | |
| 1/18/2024 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 11/13/2023 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2023 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2023 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2023 | Invitae Corporation | NVTA | Maintain | Underweight (N/A) |
|
Details | ||
| 10/16/2023 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2023 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/16/2023 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2023 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/16/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/10/2023 | Exact Sciences | EXAS | Upgrade | Overweight (Neutral) |
62.70 (100.90) |
60.93% | Details | |
| 9/27/2023 | Guardant Health | GH | Upgrade | Overweight (Neutral) |
26.26 (141.91) |
440.4% | Details | |
| 8/14/2023 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2023 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | Guardant Health | GH | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | Exact Sciences | EXAS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2023 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 6/29/2023 | Quest Diagnostics | DGX | New Coverage | Neutral (N/A) |
142.56 (204.70) |
43.59% | Details | |
| 5/15/2023 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2023 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2023 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 4/11/2023 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2022 | Adeptus Biotechnologies Corp. | ADPT | Upgrade | Overweight (Neutral) |
7.26 (20.12) |
177.13% | Details | |
| 12/15/2022 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 12/8/2022 | Fulgent Genetics | FLGT | Downgrade | Neutral (Overweight) |
36.09 (19.22) |
-46.74% | Details | |
| 11/14/2022 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2022 | Fulgent Genetics | FLGT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2022 | Exact Sciences | EXAS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/14/2022 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/1/2022 | Guardant Health | GH | Downgrade | Neutral (Overweight) |
47.86 (141.91) |
196.51% | Details | |
| 10/26/2022 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/10/2022 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 8/17/2022 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2022 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/1/2022 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 7/26/2022 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/12/2022 | Neogen | NEOG | New Coverage | Neutral (N/A) |
23.39 (9.60) |
-58.96% | Details | |
| 7/12/2022 | IDEXX Laboratories | IDXX | New Coverage | Overweight (N/A) |
378.45 (564.34) |
49.12% | Details | |
| 7/12/2022 | Zoetis Inc. | ZTS | New Coverage | Overweight (N/A) |
177.98 (78.47) |
-55.91% | Details | |
| 7/12/2022 | Elanco Animal Health | ELAN | New Coverage | Neutral (N/A) |
20.45 (24.24) |
18.53% | Details | |
| 6/3/2022 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Neutral (N/A) |
7.99 (20.12) |
151.81% | Details | |
| 6/3/2022 | Neogenomics | NEO | New Coverage | Overweight (N/A) |
8.05 (13.58) |
68.7% | Details | |
| 6/3/2022 | Invitae Corporation | NVTA | Maintain | Underweight (N/A) |
|
Details | ||
| 6/3/2022 | Exact Sciences | EXAS | New Coverage | Neutral (N/A) |
48.48 (104.91) |
116.4% | Details | |
| 6/3/2022 | Guardant Health | GH | New Coverage | Overweight (N/A) |
38.65 (141.91) |
267.17% | Details | |
| 3/1/2022 | Fulgent Genetics | FLGT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/4/2022 | Fulgent Genetics | FLGT | New Coverage | Overweight (N/A) |
64.97 (19.22) |
-70.42% | Details |
